NCT00198432View on ClinicalTrials.gov

Chemoradiotherapy of NSCLC Stage IIIB

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

December 31, 2006

Conditions
NSCLC Stage IIIBConcomitant Radiochemotherapy
Interventions
DRUG

Paclitaxel, vinorelbine, cisplatin

Trial Locations (1)

42000

CHU Saint-Etienne Pneumologie, Saint-Etienne

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Pierre Fabre Laboratories

INDUSTRY

collaborator

Ligue contre le cancer, France

OTHER

lead

Intergroupe Francophone de Cancerologie Thoracique

OTHER